stars 1 stars 2 stars 3

Cannamedical® Pharma GmbH has a pharmaceutical wholesale licence in accordance with 52a of the Medicines Act (AMG) and a permit to handle narcotics in accordance with § 3 of the Act on Narcotics (BtMG). As the only independent German cannabis wholesaler we cooperate with several selected international producers. Our independence guarantees a qualitatively and quantitatively unique range of medical cannabis on the German market. In addition to our independence we were also one of the first companies that received the license to import cannabis to Europe. We are one of the pioneers in the European cannabis industry and have become specialists in GMP processing and authority auditing. With our strong team, we are committed to act responsibly and ethically at all times. We fulfill our social responsibility and tasks with passion and dedication. Our clear focus lies on ensuring the adequate supply of medical care for patients, providing information within a professional framework and satisfying our customers.

Cannamedical Pharma Questions

The Cannamedical Pharma annual revenue was $6.1 million in 2026.

Burak Seckinok is the Sales Director of Cannamedical Pharma.

25 people are employed at Cannamedical Pharma.

Cannamedical Pharma is based in Köln, Nordrhein-Westfalen.

The NAICS codes for Cannamedical Pharma are [3254, 32, 32541, 325].

The SIC codes for Cannamedical Pharma are [283, 28].

Top Cannamedical Pharma Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users